48
Participants
Start Date
October 15, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
June 30, 2028
PGT121.414.LS
Administered SC in the thigh
VRC07-523LS
Administered SC in the thigh
Site 8950, FAMCRU, Cape Town
Site 5114, Bronx-Lebanon Hospital Center, The Bronx
Site 5013, Jacobi Medical Center Bronx, The Bronx
Site 5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho, Kericho
Site 5092, Johns Hopkins University Baltimore, Baltimore
Site 5030, Emory University School of Medicine, Atlanta
Site 5051, University of Florida Jacksonville, Jacksonville
Site 5127, Pediatric Perinatal HIV, Miami
Site 6501, St. Jude Children's Research Hospital, Memphis
Site 5083, Rush University Cook County Hospital Chicago, Chicago
Site 5128, Baylor College of Medicine/Texas Children's Hospital, Houston
Site 5052, University of Colorado Denver, Aurora
Site 5112, David Geffen School of Medicine at UCLA, Los Angeles
Site 5072, Hospital Federal dos Servidores do Estado, Rio de Janeiro
Site 5097, Hospital Geral De Nova Iguacu Brazil, Rio de Janeiro
Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research, San Juan
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Mental Health (NIMH)
NIH
National Institute of Allergy and Infectious Diseases Vaccine Research Center (NIAID VRC)
UNKNOWN
National Institute of Allergy and Infectious Diseases (NIAID)
NIH